Wednesday, October 22, 2014 9:34:50 PM
Those attending the meeting were told that the sole iteration of the machine (Engel E-100) concerning non-CE production was delivered to Rancho Santa Margarita. He, naturally, would not and did not address what machines were delivered, if any, to Apple.
As all Engel LQMT machines must be approved for sale by LQMT to the non-CE market [please look at the Engel website for the clarification on how orders for a machine are made (i.e. through LQMT RSM)] Therefore, Steipp would know immediately of any shipments of the latest iteration machine to either a LQMT MSR customer or a LQM CLM.
No CLM's have been nominated. Only two MSR's have been nominated, and quite recently, with one coming on deck.
As far as Visser Precision, it is difficult to know what iteration of the Engel machine they have, but for sure it is at least one or two iterations behind the machine now in RSM for R&D and small commercial runs.
Bottom line, we are looking at, IMO, at least 6 months before any new machine would be delivered either to LQMT itself, new CLM(s) or an in house customer.
Not so sure that MTRN's CC tomorrow will shed any light on shipments of LQMT INGOTS.
Recall, that two hundred thousand pounds is the max capacity of MTRN's plant. If the cost of an ingot is (being quite liberal) $30 or so we would be looking at a total sale of material around USD6 million per year. Say, 10 million tops (if the cost is higher. That is 2.5 million per quarter at max production.
I do not see how that small dollar amount will reflect on the whole of the MTRN's financial statements, particularly, since they don't give a breakdown of the component sales in the Beryllium and Composite Devision.
Some one else please chip in. Say, OOO or Pappy, if he is around.
I wouldn't want to have the last word on this if I am wrong. Finally, we have no certainty that MTRN is supplying APPL, though, I suspect that they would be one of its two primary suppliers (Apple wants redundancy).
Recent LQMT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 10:15:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2023 10:26:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:37:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 08:41:42 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM